Preeclampsia, which involves excess protein in the urine as well as hypertension in pregnancy, affects up to 5-8% of pregnancies and 50-75,000 women die from preeclampsia-related complications every year [1]. This is a dangerous obstacle that can affect both the mother and fetus, often leading to premature birth. For those in low-resource settings, more than 250,000 neonatal preterm births are a result of preeclampsia because these mothers lack the necessary access to healthcare and the opportunity to seek out medical expertise. In this study, we are automating a detection tool for preeclampsia, referred to as the supine pressor test (SPT), to allow clinicians and expecting mothers to track the risk for preeclampsia longitudinally throughout pregnancy
